Kezuo Hou

3.7k total citations
116 papers, 2.9k citations indexed

About

Kezuo Hou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kezuo Hou has authored 116 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 56 papers in Oncology and 34 papers in Cancer Research. Recurrent topics in Kezuo Hou's work include RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (13 papers) and Lung Cancer Treatments and Mutations (13 papers). Kezuo Hou is often cited by papers focused on RNA modifications and cancer (13 papers), Cancer-related molecular mechanisms research (13 papers) and Lung Cancer Treatments and Mutations (13 papers). Kezuo Hou collaborates with scholars based in China, United States and Saint Kitts and Nevis. Kezuo Hou's co-authors include Xiujuan Qu, Yunpeng Liu, Xiaofang Che, Yibo Fan, Ling Xu, Ce Li, Yuee Teng, Jinglei Qu, Xuejun Hu and Zhi Li and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Kezuo Hou

114 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kezuo Hou China 31 1.9k 910 909 551 408 116 2.9k
Xiaofang Che China 35 2.2k 1.2× 1.2k 1.3× 1.2k 1.3× 600 1.1× 533 1.3× 158 3.6k
Soner Altiok United States 27 2.1k 1.1× 646 0.7× 1.3k 1.4× 758 1.4× 433 1.1× 60 3.5k
Qinghua Zhou China 30 1.6k 0.8× 818 0.9× 571 0.6× 401 0.7× 361 0.9× 133 2.7k
Linda Oyang China 25 1.7k 0.9× 1.1k 1.2× 605 0.7× 496 0.9× 349 0.9× 47 2.7k
Longzheng Xia China 24 1.7k 0.9× 1.1k 1.2× 599 0.7× 475 0.9× 329 0.8× 43 2.7k
George G. Chen Hong Kong 31 2.2k 1.2× 1.1k 1.2× 862 0.9× 397 0.7× 421 1.0× 119 3.6k
Meidan Ying China 34 2.2k 1.2× 813 0.9× 705 0.8× 493 0.9× 575 1.4× 95 3.3k
Xianjie Jiang China 19 1.5k 0.8× 949 1.0× 997 1.1× 782 1.4× 413 1.0× 42 2.9k
Xiangjian Luo China 31 1.8k 0.9× 1.2k 1.3× 726 0.8× 353 0.6× 279 0.7× 71 2.9k

Countries citing papers authored by Kezuo Hou

Since Specialization
Citations

This map shows the geographic impact of Kezuo Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kezuo Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kezuo Hou more than expected).

Fields of papers citing papers by Kezuo Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kezuo Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kezuo Hou. The network helps show where Kezuo Hou may publish in the future.

Co-authorship network of co-authors of Kezuo Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Kezuo Hou. A scholar is included among the top collaborators of Kezuo Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kezuo Hou. Kezuo Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Che, Xiaofang, Jinyan Wang, Ce Li, et al.. (2025). T-bet+CD8+ T cells govern anti-PD-1 responses in microsatellite-stable gastric cancers. Nature Communications. 16(1). 3905–3905. 3 indexed citations
2.
Chen, Yang, Ximing Wang, Xiaofang Che, et al.. (2023). Hypoxia-induced ALDH3A1 promotes the proliferation of non-small-cell lung cancer by regulating energy metabolism reprogramming. Cell Death and Disease. 14(9). 617–617. 28 indexed citations
3.
Wang, Duo, Xiujuan Qu, Wenqing Lü, et al.. (2021). N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1. Frontiers in Oncology. 11. 681280–681280. 41 indexed citations
4.
Che, Xiaofang, Guohui Li, Anhui Wang, et al.. (2020). Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex. Journal of Experimental & Clinical Cancer Research. 39(1). 11 indexed citations
5.
Wang, Shuo, Xiujuan Qu, Lili Cao, et al.. (2020). <p>Assessment of Nine Driver Gene Mutations in Surgically Resected Samples from Patients with Non-Small-Cell Lung Cancer</p>. Cancer Management and Research. Volume 12. 4029–4038. 6 indexed citations
6.
Zhang, Min, Yibo Fan, Xiaofang Che, et al.. (2020). 5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients. Frontiers in Oncology. 10. 492–492. 46 indexed citations
7.
Zhao, Huan, Chunlei Zheng, Yizhe Wang, et al.. (2020). miR-1323 Promotes Cell Migration in Lung Adenocarcinoma by Targeting Cbl-b and Is an Early Prognostic Biomarker. Frontiers in Oncology. 10. 181–181. 19 indexed citations
8.
Yang, Zichang, Xiaonan Shi, Ce Li, et al.. (2018). Long non-coding RNA UCA1 upregulation promotes the migration of hypoxia-resistant gastric cancer cells through the miR-7-5p/EGFR axis. Experimental Cell Research. 368(2). 194–201. 50 indexed citations
9.
Qi, Haiyan, Xiujuan Qu, Jing Liu, et al.. (2018). Bufalin induces protective autophagy by Cbl‐b regulating mTOR and ERK signaling pathways in gastric cancer cells. Cell Biology International. 43(1). 33–43. 29 indexed citations
10.
Xu, Ling, Xiujuan Qu, Xuejun Hu, et al.. (2018). β‐elemene increases the sensitivity of gastric cancer cells to TRAIL by promoting the formation of DISC in lipid rafts. Cell Biology International. 42(10). 1377–1385. 19 indexed citations
11.
Wen, Ti, Zhenning Wang, Yi Li, et al.. (2017). A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer. Cancer Immunology Research. 5(7). 524–534. 46 indexed citations
12.
Zhang, Ye, Xiujuan Qu, Xiaofang Che, et al.. (2017). miR‐200a enhances TRAIL‐induced apoptosis in gastric cancer cells by targeting A20. Cell Biology International. 42(5). 506–514. 24 indexed citations
13.
Shi, Xiaonan, Chunlei Zheng, Ce Li, et al.. (2017). 4‐Phenybutyric acid promotes gastric cancer cell migration via histone deacetylase inhibition‐mediated HER3/HER4 up‐regulation. Cell Biology International. 42(1). 53–62. 10 indexed citations
14.
15.
Tong, Xiaoguang, Mark Barbour, Kezuo Hou, et al.. (2015). Interleukin‐33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways. Molecular Oncology. 10(1). 113–125. 75 indexed citations
16.
Qu, Xiujuan, et al.. (2011). PD98059 enhancing the effects of oxaliplatin on human colorectal cancer RKO cells mediated by downregulation of GST-π expression. Zhonghua linchuang yishi zazhi. 5(23). 6957–6960. 1 indexed citations
17.
Xu, Yingying, Xiujuan Qu, Xue Zhang, et al.. (2009). Midkine positively regulates the proliferation of human gastric cancer cells. Cancer Letters. 279(2). 137–144. 36 indexed citations
18.
Qu, Jinglei, Xiujuan Qu, Mingfang Zhao, et al.. (2009). The role of cbl family of ubiquitin ligases in gastric cancer exosome-induced apoptosis of Jurkat T cells. Acta Oncologica. 48(8). 1173–1180. 40 indexed citations
19.
Li, Dan, Xiujuan Qu, Kezuo Hou, et al.. (2008). PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. Anti-Cancer Drugs. 20(1). 59–64. 141 indexed citations
20.
Hou, Kezuo. (2005). Inhibition effect of eethanol extract of Chinese toad venom on H22 ascites and solid tumors and its toxicity in mice. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaofang Che Breakdown of academic impact, for papers by Soner Altiok Breakdown of academic impact, for papers by Qinghua Zhou Breakdown of academic impact, for papers by Linda Oyang Breakdown of academic impact, for papers by Longzheng Xia Breakdown of academic impact, for papers by George G. Chen Breakdown of academic impact, for papers by Meidan Ying Breakdown of academic impact, for papers by Xianjie Jiang Breakdown of academic impact, for papers by Xiangjian Luo
Rankless by CCL
2026